相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Diversity of Plasmodium falciparum and Distribution of Antimalarial Drug Resistance Mutations in Symptomatic and Asymptomatic Infections
Elangwe M. Sarah-Matio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B. Sirima et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
The mechanistic analysis of founder virus data in challenge models
Ana M. Ortega-Villa et al.
STATISTICS IN MEDICINE (2021)
Multiplicity of Asymptomatic Plasmodium falciparum Infections and Risk of Clinical Malaria: A Systematic Review and Pooled Analysis of Individual Participant Data
Martina Eldh et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Co-transmission of Related Malaria Parasite Lineages Shapes Within-Host Parasite Diversity
Standwell C. Nkhoma et al.
CELL HOST & MICROBE (2020)
Sex-based differences in clearance of chronic Plasmodium falciparum infection
Jessica Briggs et al.
ELIFE (2020)
Highly heterogeneous residual malaria risk in western Thailand
Wang Nguitragool et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2019)
Dynamics of Plasmodium falciparum genetic diversity among asymptomatic and symptomatic children in three epidemiological areas in Cote d'Ivoire
Akpa Paterne Gnagne et al.
PATHOGENS AND GLOBAL HEALTH (2019)
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
Aimee R. Taylor et al.
NATURE COMMUNICATIONS (2019)
Sieve analysis using the number of infecting pathogens
Dean Follmann et al.
BIOMETRICS (2018)
Malaria Epidemiology at the Clone Level
Cristian Koepfli et al.
TRENDS IN PARASITOLOGY (2017)
The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea
Natalie E. Hofmann et al.
ELIFE (2017)
Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo
Hypolite Muhindo Mavoko et al.
PLOS ONE (2016)
Incorporating founder virus information in vaccine field trials
Dean Follmann et al.
BIOMETRICS (2015)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model
Leanne J. Robinson et al.
PLOS MEDICINE (2015)
Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response
Danielle I. Stanisic et al.
INFECTION AND IMMUNITY (2015)
Geographical variation in Plasmodium vivax relapse
Katherine E. Battle et al.
MALARIA JOURNAL (2014)
Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
Julia K. Nunes et al.
VACCINE (2014)
Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait
Lauren Gong et al.
BLOOD (2012)
MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines
Kirsten S. Vannice et al.
MALARIA JOURNAL (2012)
Measuring force of infection and vaccine effects on transmission stages in clinical trials of experimental malaria vaccines
Ingrid Felger et al.
MALARIA JOURNAL (2012)
Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
Ivo Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Biomarkers and surrogate endpoints in clinical trials
Thomas R. Fleming et al.
STATISTICS IN MEDICINE (2012)
Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
Marc Lievens et al.
MALARIA JOURNAL (2011)
Determinants of relapse periodicity in Plasmodium vivax malaria
Nicholas J. White
MALARIA JOURNAL (2011)
Biomarkers and surrogate end points-the challenge of statistical validation
Marc Buyse et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
John N. Waitumbi et al.
PLOS ONE (2009)
Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model
Andrew R. Wargo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection
Sonia Enosse et al.
PLOS CLINICAL TRIALS (2006)
A modified Poisson regression approach to prospective studies with binary data
GY Zou
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Endpoints in vaccine trials
MG Hudgens et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2004)
Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea
A Cortes et al.
EXPERIMENTAL PARASITOLOGY (2004)
Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season
A Ofosu-Okyere et al.
PARASITOLOGY (2001)
分享论文
